Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD.

Singh D, Beeh KM, Colgan B, Kornmann O, Leaker B, Watz H, Lucci G, Geraci S, Emirova A, Govoni M, Nandeuil MA

Open source

DOI
10.1186/s12931-019-1142-7
Published
2019 Aug 9
Container
Respiratory research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12931-019-1142-7,
  title = {Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD.},
  author = {Singh D and Beeh KM and Colgan B and Kornmann O and Leaker B and Watz H and Lucci G and Geraci S and Emirova A and Govoni M and Nandeuil MA},
  year = {2019},
  journal = {Respiratory research},
  doi = {10.1186/s12931-019-1142-7},
  url = {https://doi.org/10.1186/s12931-019-1142-7}
}

RIS

TY  - JOUR
TI  - Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD.
AU  - Singh D
AU  - Beeh KM
AU  - Colgan B
AU  - Kornmann O
AU  - Leaker B
AU  - Watz H
AU  - Lucci G
AU  - Geraci S
AU  - Emirova A
AU  - Govoni M
AU  - Nandeuil MA
PY  - 2019
JO  - Respiratory research
DO  - 10.1186/s12931-019-1142-7
UR  - https://doi.org/10.1186/s12931-019-1142-7
ER  - 

APA

D, S., KM, B., B, C., O, K., B, L., H, W., G, L., S, G., A, E., M, G., & MA, N. (2019). Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD.. Respiratory research. https://doi.org/10.1186/s12931-019-1142-7

Source records